NCT01592916

Brief Summary

The investigators previous studies of aerobic exercise in women with fibromyalgia (FM) have shown that exercise improves body functions and/or symptom severity in most patients, but not in all. About a third of patients with FM have been shown to have low levels of IGF-1. The purpose of this project is to study individual and biological factors that interact with outcomes of short-term (acute) exercise in FM. Method. A controlled prospective exercise study. Thirty women with FM and 30 healthy age-matched women, aged 20-50 years, will be recruited to the study. Two 15-minute ergometer bicycle exercise tests will be conducted in feasting patients, separated by one month. The first exercise test is at a low and the second at a high intensity. Measurements comprise blood test, pain rating and pain threshold, conducted before and after the test. The levels of IGF-1, IL-6 and IL-8 will be measured, and the changes in them will be related to health status and pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 7, 2012

Completed
3 days until next milestone

Study Start

First participant enrolled

May 10, 2012

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 23, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 23, 2012

Completed
Last Updated

February 5, 2018

Status Verified

February 1, 2018

Enrollment Period

7 months

First QC Date

May 4, 2012

Last Update Submit

February 1, 2018

Conditions

Keywords

FibromyalgiaPainWomenExerciseIGF1

Outcome Measures

Primary Outcomes (1)

  • IGF1 level

    Ergometer cycle test of 15 minutes at low respective high intensity. Blood test is done before and after exercise. Change in quantity of IGF1 is measured.

    15 min

Secondary Outcomes (3)

  • Pain rating

    15 minutes

  • Pain threshold

    15 minutes

  • Interleukin 6 and 8

    15 minutes

Study Arms (2)

Fibromyalgia

Women with fibromyalgia, aged 20-50 years

Healthy controls

Women without severe disease, aged 20-50 years

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The participants are recruited from previous studies.

You may qualify if:

  • clinical diagnosis of fibromyalgia
  • age 20-50 years

You may not qualify if:

  • heart disease
  • neurological disease
  • severe osteoarthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University Hospital, Dept of Physical Therapy

Gothenburg, 41345, Sweden

Location

Related Publications (1)

  • Mannerkorpi K, Landin-Wilhelmsen K, Larsson A, Cider A, Arodell O, Bjersing JL. Acute effects of physical exercise on the serum insulin-like growth factor system in women with fibromyalgia. BMC Musculoskelet Disord. 2017 Jan 25;18(1):37. doi: 10.1186/s12891-017-1402-y.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood serum

MeSH Terms

Conditions

FibromyalgiaPainMotor Activity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Kaisa Mannerkorpi, Assoc prof

    Göteborg University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2012

First Posted

May 7, 2012

Study Start

May 10, 2012

Primary Completion

November 23, 2012

Study Completion

November 23, 2012

Last Updated

February 5, 2018

Record last verified: 2018-02

Locations